Implantable cardioverter defibrillators work - So why aren't we using them?

CMAJ. Canadian Medical Association Journal

Volumn 177, Issue 1, 2007, Pages 49-51

  Simpson, Christopher S ^a,b,c  

^a HOTEL DIEU HOSPITAL   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

^c KINGSTON GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANADA; CULTURAL FACTOR; CULTURAL VALUE; DEFIBRILLATOR; ECONOMICS; HEALTH CARE SYSTEM; HEART ARREST; HEART DEATH; HEART INFARCTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERCHOLESTEROLEMIA; KNOWLEDGE; MORTALITY; NOTE; PACEMAKER; PATIENT CARE; PATIENT DECISION MAKING; PHYSICIAN; RISK FACTOR; SOCIAL ASPECT; SURVIVOR; UNITED STATES;

EID: 34447286240     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.070470     Document Type: Note

References (10)

1. The Antiarrhythmics versus Implantable Defibrillators AVID Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337:1576-83.
2. Connolly SJ, Gent M, Roberts RS, et al. Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-302.
3. Kuck KH, Cappato R, Siebels J, et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:748-54.
4. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure [published erratum in N Engl J Med 2005; 352:2146]. N Engl J Med 2005;352:225-37.
5. Kadish A, Dyer A, Daubert JP, et al. Defibrillators in non-ischemic cardiomyopathy treatment evaluation (DEFINITE). N Engl J Med 2004;350:2151-8.
6. Moss AJ, Zareba W, Hall WJ at al. Multicenter Automatic Defibrillator Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
7. Birnie DH, Sambell C, Johansen H, et al. Use of implantable cardioverter defibrillators in Canadian and US survivors of out-of-hospital cardiac arrest. CMAJ 2007; 177:41-6.
8. Simpson CS, Hoffmaster B, Dorian P. Downward delegation of implantable cardioverter defibrillator decision-making in a restricted-resource environment: the pitfalls of bedside rationing [review]. Can J Cardiol 2005;21:595-9.
9. Wilson S, Kadwell S, Kane C, et al. Variations in utilization of implantable cardioverter defibrillators across Canada. Can J Cardiol 2004;20(Suppl D):147D.
10. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998;339:1349-57.